<?xml version="1.0" encoding="UTF-8"?>
<ref id="B63-pharmaceutics-10-00039">
 <label>63.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sv√§rd</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Spiers</surname>
    <given-names>J.P.</given-names>
   </name>
   <name>
    <surname>Mulcahy</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Hennessy</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Nuclear receptor mediated induction of CYP450 by antiretrovirals: Functional consequences of NR1I2 (PXR) polymorphisms and differential prevalence in whites and sub-Saharan Africans</article-title>
  <source>J. Acquir. Immune Defic. Syndr.</source>
  <year>2010</year>
  <volume>55</volume>
  <fpage>536</fpage>
  <lpage>549</lpage>
  <pub-id pub-id-type="doi">10.1097/QAI.0b013e3181f52f0c</pub-id>
  <?supplied-pmid 20861742?>
  <pub-id pub-id-type="pmid">20861742</pub-id>
 </element-citation>
</ref>
